Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In search of an anti-inflammatory drug for Alzheimer disease.

Literature DB >> 31919414

In search of an anti-inflammatory drug for Alzheimer disease.

Erika Gyengesi¹, Gerald Münch^2,3.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2020 PMID： 31919414 DOI： 10.1038/s41582-019-0307-9

Source DB: PubMed Journal: Nat Rev Neurol ISSN： 1759-4758 Impact factor: 42.937

× No keyword cloud information.

1 in total

1. Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.

Authors: Fernando L Pagan; Michaeline L Hebron; Barbara Wilmarth; Yasar Torres-Yaghi; Abigail Lawler; Elizabeth E Mundel; Nadia Yusuf; Nathan J Starr; Muhammad Anjum; Joy Arellano; Helen H Howard; Wangke Shi; Sanjana Mulki; Tarick Kurd-Misto; Sara Matar; Xiaoguang Liu; Jaeil Ahn; Charbel Moussa
Journal: JAMA Neurol Date: 2020-03-01 Impact factor: 18.302

1 in total

20 in total

1. Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation.

Authors: Wen Chai; Ji Zhang; Zhengbing Xiang; Honglian Zhang; Zhujun Mei; Hongbing Nie; Renxu Xu; Ping Zhang
Journal: Metab Brain Dis Date: 2022-03-10 Impact factor: 3.584

2. Editorial: Role of Inflammation in Neurodegenerative Diseases.

Authors: Maya Koronyo-Hamaoui; Bhakta Prasad Gaire; Sally Ann Frautschy; Jorge Ivan Alvarez
Journal: Front Immunol Date: 2022-06-21 Impact factor: 8.786

Review 3. Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

Authors: Awanish Mishra; Ritam Bandopadhyay; Prabhakar Kumar Singh; Pragya Shakti Mishra; Neha Sharma; Navneet Khurana
Journal: Metab Brain Dis Date: 2021-08-13 Impact factor: 3.584

4. N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

Authors: Shih Chang Hsueh; Weiming Luo; David Tweedie; Dong Seok Kim; Yu Kyung Kim; Inho Hwang; Jung-Eun Gil; Baek-Soo Han; Yung-Hsiao Chiang; Warren Selman; Barry J Hoffer; Nigel H Greig
Journal: ACS Pharmacol Transl Sci Date: 2021-03-30

5. SIRT1-Dependent Upregulation of BDNF in Human Microglia Challenged with Aβ: An Early but Transient Response Rescued by Melatonin.

Authors: Grazia Ilaria Caruso; Simona Federica Spampinato; Giuseppe Costantino; Sara Merlo; Maria Angela Sortino
Journal: Biomedicines Date: 2021-04-24

In search of an anti-inflammatory drug for Alzheimer disease.

1. Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial.

1. Potential of nobiletin against Alzheimer's disease through inhibiting neuroinflammation.

2. Editorial: Role of Inflammation in Neurodegenerative Diseases.

Review 3. Neuroinflammation in neurological disorders: pharmacotherapeutic targets from bench to bedside.

4. N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

5. SIRT1-Dependent Upregulation of BDNF in Human Microglia Challenged with Aβ: An Early but Transient Response Rescued by Melatonin.

Review 6. Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease.

Review 7. Tau at the interface between neurodegeneration and neuroinflammation.

8. Characterisation of the Mouse Cerebellar Proteome in the GFAP-IL6 Model of Chronic Neuroinflammation.

Review 9. Immune Response in Neurological Pathology: Emerging Role of Central and Peripheral Immune Crosstalk.

Review 10. Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease.